This section is password-protected. Please enter the password to view.
← Back to Sleep Health homeA sleep titration study is a vital, monitored assessment performed overnight to find the exact customized settings for a breathing support machine, commonly known as Positive Airway Pressure (PAP) therapy. This specialized test is necessary for individuals who have been diagnosed with, or are strongly suspected of having, a breathing problem while they sleep.
In advanced clinical settings, such as the O2 SleepWell Laboratory (situated within the Cura Day Surgery Centre), or in off-site locations like homes, hospitals, or hotels, this procedure is overseen by an attended sleep technologist. The goal is to determine the precise level of air pressure that keeps the airway continuously open, thereby stopping interruptions in breathing, minimizing shallow breathing, and eliminating snoring.
A titration study serves as a personalized adjustment session for your breathing treatment. The device used, such as the Lowenstein Prismalab, delivers pressurized air to act as an internal support system, preventing the throat from closing during sleep. Because the required pressure varies significantly from person to person based on their airway size and the severity of their condition, this overnight assessment is crucial for prescribing effective long-term therapy.
The versatile Prismalab device provides all the modes and functions necessary for comprehensive titration. The modes tested may include:
Simple Pressure (CPAP): This therapy delivers one constant level of air pressure throughout the night. The pressure is usually started low, at 4cm H2O.
Bilevel Pressure (BiPAP): This mode uses two different pressures: a higher pressure when you breathe in (Inspiratory Positive Airway Pressure, or IPAP) and a lower pressure when you breathe out (Expiratory Positive Airway Pressure, or EPAP). Minimum starting pressures are typically 8cm H2O (inhalation) and 4cm H2O (exhalation).
Complex Support Modes: For more challenging and complex breathing patterns, specialized modes are available. These include devices offering Anticyclic Servoventilation (AcSV), which is used for conditions like Cheyne-Stokes Respiration or certain types of central breathing interruptions.
Adding a monitor for transcutaneous carbon dioxide (TcCO2) allows doctors to continuously measure the carbon dioxide level in the skin. This is essential because it provides continuous insight into how effectively the patient is moving air in and out, known as ventilation.
Assessing Treatment: Monitoring TcCO2 helps evaluate the sufficiency and quality of nighttime ventilation.
Early Detection: Tracking changes in carbon dioxide levels can help recognize developing breathing depression, especially when changes are made to medication or device settings.
The study utilizes monitoring equipment, such as the Nox A1s system. The technologist connects sensors to track multiple body functions:
Sleep Stages: Brain activity (EEG) and eye movement (EOG) determine when you are in different phases of sleep.
Breathing: Movement of the chest and abdomen (using RIP belts) and airflow/pressure are recorded.
Heart and Oxygen: Oxygen levels (SpO2) and pulse rate are monitored, often via an external oximeter connected wirelessly.
The technologist monitors this incoming data in real-time. Using the Prismalab, the pressure is gradually increased, typically in increments of at least 1cm H2O over periods no shorter than 5 minutes. These pressure adjustments can be managed remotely via special computer software. The process stops when the continuous pressure eliminates all breathing disturbances.
This study is critical for anyone diagnosed with a sleep breathing disorder, particularly Obstructive Sleep Apnea (OSA).
Other groups that significantly benefit include:
Patients with Complex or Milder Disorders: The detailed monitoring of an attended titration study is essential for diagnosing complex issues like Central Sleep Apnea or Cheyne-Stokes Respiration. Lab studies are also more sensitive in detecting milder sleep breathing disorders, especially in women and those who also experience difficulty sleeping (insomnia).
The data collected is reviewed by a sleep physician to officially select the optimal pressure and configuration for the patient's long-term therapy.
The doctor uses the information to ensure the final pressure setting achieves three key outcomes:
Breathing Control: The pressure must control the patient's obstructive breathing problems, ensuring a low rate of disturbances (preferably fewer than 5 per hour).
Oxygen Safety: The treatment must ensure that the patient’s blood oxygen is adequate.
Comprehensive Coverage: The effective pressure must be proven to work even during the most challenging sleep stages, such as when the patient is lying on their back during the deepest sleep phase (REM sleep).
Interested in this service or want to know if it's right for you?